Algocells Blog

Orthobiologics have gained a well deserved position in the musculoskeletal medicine as a new and promising non-invasive treatment applicable to many spine and musculoskeletal conditions. Every month witnesses new publications bringing more evidence, changing the practice and opening new perspectives for the future.

2021 has been announced a “Global Year About Back Pain” by leading pain organisations. Indeed back pain is a major healthcare financial burden in the developed world. Besides it hurts… And in the pandemic we spent more time at home, working in our ad-hoc “home offices”, be it a kitchen table or bedroom. We don’t have at home fancy ergonomic chairs and desks. And we move less. Hence we have seen a “pandemic” of lower back pains in recent twelve months. Let me tell you my view on back pain treatments and how this view has evolved…

Exciting news: from November our clinic and treatment facilities will be in Chelsea in London. We will be able to offer much better conditions, more space and easy access to the clinic. Our clinic will be within the Smart Clinics, although Algocells remains independent Regenexx affiliate. 

Anterior Cruciate Ligament (ACL) is a common victim of knee injuries. It is particularly vulnerable to twisting movements, such as ones during skiing, snowboarding and playing football. ACL plays a crucial role in stabilising knee joint. Its tear is one of the commonest sport injuries.

In Algocells we provide treatments which involve Platelet Rich Plasma (or stem cells) injection into C0/1, C1/2 joints and capsules, into further cervical facet joints, posterior ligaments and muscles. We also collaborate with Dr Iain Smith, a Chiropractor, who specialises in CCI and has a vast experience in treating this condition. We can also arrange an MRI imaging in London, dedicated to CCI diagnosis. The scans are assessed and interpreted by one of the leading Neuroradiologist, specialising in CCI.

We are now at a stage where we can to move forward with providing safe, effective treatments to our international patients, in accordance with UKBA and government guidelines.